ArticleJournal of personalized medicine2020

Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients.

Ilaria Grazia Zizzari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.